HomeVNDA • NASDAQ
add
Vanda Pharmaceuticals Inc.
Previous close
$4.65
Day range
$4.55 - $4.64
Year range
$3.46 - $6.75
Market cap
268.22M USD
Avg Volume
625.12K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Defense World
3 hours ago
Contrasting Vanda Pharmaceuticals (NASDAQ:VNDA) and Bioxytran (OTCMKTS:BIXT)
4.64%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 47.65M | 22.76% |
Operating expense | 56.10M | 34.38% |
Net income | -5.32M | -3,986.13% |
Net profit margin | -11.17 | -3,291.43% |
Earnings per share | — | — |
EBITDA | -9.03M | -66.81% |
Effective tax rate | 14.73% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 376.26M | -23.19% |
Total assets | 645.12M | 0.55% |
Total liabilities | 103.89M | 5.47% |
Total equity | 541.22M | — |
Shares outstanding | 58.31M | — |
Price to book | 0.50 | — |
Return on assets | -4.24% | — |
Return on capital | -5.00% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.32M | -3,986.13% |
Cash from operations | -14.58M | -611.27% |
Cash from investing | 12.06M | -65.87% |
Cash from financing | — | — |
Net change in cash | -2.46M | -107.41% |
Free cash flow | -11.42M | -121.64% |
About
Founded
2002
Headquarters
Website
Employees
203
